Table 3 CMR parameters according to gender in 56 propensity score matched patients of similar age
From: Age and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR
Female n = 28 | Male n = 28 | P value | ||
|---|---|---|---|---|
Age (years) | 55 ± 17 | 56 ± 18 | 0.82 | |
BMI (Kg/m2) | 22 ± 3 | 25 ± 3 | 0.002 | |
BSA (m2) | 1.66 ± 0.11 | 1.93 ± 0.13 | <0.001 | |
SBP (mmHg | 129 ± 20 | 138 ± 20 | 0.12 | |
HR (bpm) | 62 ± 7 | 64 ± 11 | 0.51 | |
GFR (ml/min/1.73m2) | 73 ± 16 | 77 ± 13 | 0.28 | |
Hematocrit (%) | 41 ± 2 | 44 ± 4 | 0.008 | |
Smoking (%) | 3 (11%) | 3 (11%) | 1.00 | |
Hypertension (%) | 6 (21%) | 7 (25%) | 0.77 | |
CV familial history (%) | 2 (7%) | 5 (18%) | 0.23 | |
Hypercholesterolemia (%) | 17 (61%) | 16 (57%) | 0.79 | |
LV EDVI(ml/m2) | 75 ± 14 | 84 ± 17 | 0.039 | |
LV ESVI(ml/m2) | 27 ± 7 | 31 ± 10 | 0.07 | |
LV EF(%) | 64 ± 4 | 63 ± 6 | 0.48 | |
LVMI(g/m2) | 51 ± 10 | 64 ± 9 | <0.001 | |
LV_Mass/Volume ratio | 0.7 ± 0.1 | 0.8 ± 0.2 | 0.017 | |
RVEDVI(ml/m2) | 77 ± 15 | 88 ± 18 | 0.011 | |
RVESVI (ml/m2) | 31 ± 8 | 39 ± 9 | 0.005 | |
RVEF(%) | 59 ± 5 | 57 ± 5 | 0.09 | |
T1 Pre contrast (ms) | Whole myoc. | 1139 ± 38 | 1109 ± 73 | 0.054 |
Septum | 1194 ± 48 | 1128 ± 103 | 0.004 | |
ECV % | Whole myoc. | 28.4 ± 3.4 | 25.1 ± 2.2 | <0.001 |
Septum | 28.8 ± 3.1 | 26.6 ± 4.4 | 0.044 | |
T2 time (ms) | Whole myoc. | 51 ± 4 | 53 ± 8 | 0.28 |
Septum | 52 ± 5 | 54 ± 8 | 0.23 | |
T2* time (ms) | Whole myoc. | 23 ± 5 | 24 ± 5 | 0.55 |
Septum | 25 ± 5 | 24 ± 6 | 0.78 | |